Company overview
PhoreMost’s SITESEEKER® platform enables the inception of First-in-class drug discovery programmes. Using this unique approach, PhoreMost is developing an internal asset pipeline in oncology and other diseases of ageing.
Additionally, PhoreMost is engaged in SITESEEKER collaborations with Pharma and Biotech across multiple therapeutic areas.